Europe Point of Care Diagnostics Market to Grow at a CAGR of 12.3% to reach US$ 20,207.60 Million from 2021 to 2028
The Europe point of care diagnostics market is expected to grow from US$ 8,948.81 million in 2021 to US$ 20,207.60 million by 2028; it is estimated to grow at a CAGR of 12.3% from 2021 to 2028.
The UK, Germany, France, Italy, and Spain are major economies in Europe. Escalating product launches and product developments is expected to drive the market growth.The number of point-of-care testing has steadily increased over the last 40 years since its widespread introduction. The Europe point of care market is likely to grow with the introduction of new products into the market, aimed at delivering inexpensive care at the facilities located at the closest-possible distances from the patients’ location. New technologies or products are being refined and improved to deliver easier to use devices with incremental improvements in analytical performance. The growth of the POC market is mainly attributed to the introduction of new devices to perform molecular testing. Many new devices have been launched in recent years. For instance, in June 2019, Abbott launched first-ever rapid POC HbA1c test to aid in the diagnosis of diabetes; this test provides results in three minutes, enabling clinicians to develop informed, individualized care plans during patient consultation. Moreover, in July 2021, BD announced launch of rapid and portable point-of-care antigen test for diagnosis of COVID-19. The new test kit is capable to deliver results within 15 minutes of the test. Besides, in December 2020, Beckman Coulter also introduced its rapid antigen kit for diagnosis of COVID-19. Similarly, in 2017, Roche Diagnostic division launched CoaguChek Vantus PoC; this system enables handheld coagulation monitoring system for the self-assessment of health. The division has also launched new point-of-care mobile application—Cobas Infinity—designed to meet the needs of point-of-care coordinators to manage important tasks on the go. Such advancements in new launched devices will propel the overall Europe POC market growth during the forecast period.
In case of COVID-19, Europe is highly affected specially France. The European economy is severely affected due to the exponential growth of COVID-19 cases in the region. Spain, Italy, Germany, France, and the UK are among the most affected European countries and number of deaths are also high. The current coronavirus (COVID-19) outbreak has been declared by WHO as a Public Health Emergency of International Concern, according to the International Health Regulation. Increasing number of coronavirus infections and demand for advanced diagnostic solutions is offering a favorable opportunity for adoption of point of care diagnostic kits in the region. Moreover, rising investments and business activities by industry players is also boosting the market even in pandemic situations. In 2020, European Medicines Agency (EMA) approved about 97 medicines for marketing authorization of which, 39 are novel drugs. Similarly, in October 2020, Eurofins introduces COVID-19 PCR tests with at-home self-sampling options in Europe region. Moreover, in October 2020, Siemens Healthineers launched rapid antigen test for diagnosis of COVID-19 in European countries. The CLINITEST rapid COVID-19 test is point of care cassette test that offers test result in 15 minutes. In addition, in April 2021, QIAGEN announced launch of Prep&Amp technology in order accelerate the COVID-19 diagnosis in Europe. The kit has received CE approval for marketing and distribution in Europe, also, the company has submitted its product for EUA (Emergency Use Application) in US. Such activities are likely to have constructive impact on market growth.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe point of care diagnostics market. The Europe point of care diagnostics market is expected to grow at a good CAGR during the forecast period.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Europe Point of Care Diagnostics Market Segmentation
Europe Point of Care Diagnostics Market – By Product
- Glucose Monitoring Products
- Infectious Disease Testing Products
- HIV Testing
- Influenza Testing
- Sexually Transmitted Disease (STD) Testing
- Hepatitis C Testing
- Healthcare-Associated Infection (HAI) Testing
- Tropical Disease Testing
- Respiratory Infection Testing
- Other Infectious Disease Testing
- Cardiometabolic Testing Products
- Pregnancy and Fertility Testing Products
- Coagulation Testing Products
- Tumor/Cancer Marker Testing Products
- Cholesterol Testing Products
- Urinalysis Testing Products
- Hematology Testing Products
- Other POC Products
Europe Point of Care Diagnostics Market – By Prescription Mode
- Prescription-Based Testing
- OTC Testing
Europe Point of Care Diagnostics Market – By End User
- Professional Diagnostic Centers
- Hospitals
- Clinical Laboratories
- Outpatient Healthcare
- Ambulatory Care Settings
- Home Care
- Research Laboratories
- Others
Europe Point of Care Diagnostics Market, by Country
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Europe Point of Care Diagnostics Market -Companies Mentioned
- Abbott
- BD
- bioMerieux SA
- BIO-RAD LABORATORIES INC.
- Danaher
- F. HOFFMANN-LA ROCHE LTD.
- Johnson and Johnson Services, Inc.
- Nova Biomedical
- Polymer Technology Systems, Inc. (PTS)
- Siemens AG
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, Prescription Mode, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
UK, Germany, France, Italy, Russia
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Point of Care Diagnostics Market – By Product
1.3.2 Europe Point of Care Diagnostics Market – By Prescription Mode
1.3.3 Europe Point of Care Diagnostics Market – By End User
1.3.4 Europe Point of Care Diagnostics Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Point of Care Diagnostics Market – Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
5. Europe Point of Care Diagnostics Market – Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Rising Prevalence of Infectious Diseases
5.1.2 Escalating Product Launches and Product Developments
5.1.3 Growing Number of CLIA-waived POC tests
5.2 Market Restraints
5.2.1 Increasing Product Recalls in Market
5.3 Market Opportunities
5.3.1 Escalating Number of Conferences and Events
5.4 Future Trends
5.4.1 Burgeoning Use of Home-Based POC Devices
5.5 Impact Analysis
6. Point of Care Diagnostics Market – Europe Analysis
6.1 Europe Point of Care Diagnostics Market Revenue Forecast and Analysis
7. Europe Point of Care Diagnostics Market Analysis– by Product
7.1 Overview
7.2 Europe Point of Care Diagnostics Market, By Product 2020 & 2028 (%)
7.3 Glucose Monitoring
7.3.1 Overview
7.3.2 Glucose Monitoring Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Infectious Disease Testing
7.4.1 Overview
7.4.2 Infectious Disease Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.3 HIV Testing
7.4.3.1 Overview
7.4.3.2 HIV Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.4 Influenza Testing
7.4.4.1 Overview
7.4.4.2 Influenza Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.5 Sexually Transmitted Disease (STD) Testing
7.4.5.1 Overview
7.4.5.2 Sexually Transmitted Disease (STD) Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.6 Hepatitis C Testing
7.4.6.1 Overview
7.4.6.2 Hepatitis C Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.7 Healthcare-Associated Infection (HAI) Testing
7.4.7.1 Overview
7.4.7.2 Healthcare-Associated Infection (HAI) Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.8 Tropical Disease Testing
7.4.8.1 Overview
7.4.8.2 Tropical Disease Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.9 Respiratory Infection Testing
7.4.9.1 Overview
7.4.9.2 Respiratory Infection Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.10 Other Infectious Disease
7.4.10.1 Overview
7.4.10.2 Others Infection Disease Market Revenue and Forecasts to 2028 (US$ Mn)
7.5 Cardiometabolic Testing
7.5.1 Overview
7.5.2 Cardiometabolic Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.6 Pregnancy and Fertility Testing
7.6.1 Overview
7.6.2 Pregnancy and Fertility Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.7 Coagulation Testing
7.7.1 Overview
7.7.2 Coagulation Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.8 Tumor/Cancer Marker Testing
7.8.1 Overview
7.8.2 Tumor/Cancer Marker Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.9 Cholesterol Testing
7.9.1 Overview
7.9.2 Cholesterol Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.10 Urinalysis Testing
7.10.1 Overview
7.10.2 Urinalysis Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.11 Haematology Testing
7.11.1 Overview
7.11.2 Haematology Testing Revenue and Forecasts to 2028 (US$ Mn)
7.12 Other POC
7.12.1 Overview
7.12.2 Other POC Market Revenue and Forecasts to 2028 (US$ Mn)
8. Europe Point of Care Diagnostics Market Analysis– by Prescription Mode
8.1 Overview
8.2 Europe Point of Care Diagnostics Market, By Prescription Mode 2020 & 2028 (%)
8.3 Prescription-Based Testing Market
8.3.1 Overview
8.3.2 Prescription-Based Testing Market Revenue and Forecasts to 2028 (US$ Mn)
8.4 OTC Testing Market
8.4.1 Overview
8.4.2 OTC Testing Market Revenue and Forecasts to 2028 (US$ Mn)
9. Europe Point of Care Diagnostics Market Analysis– by End User
9.1 Overview
9.2 Europe Point of Care Diagnostics Market, By End User 2020 & 2028 (%)
9.3 Professional Diagnostic Centers
9.3.1 Overview
9.3.2 Professional Diagnostic Centers Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.3 Hospitals
9.3.3.1 Overview
9.3.3.2 Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.4 Clinical Laboratories
9.3.4.1 Overview
9.3.4.2 Clinical Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.5 Outpatient Healthcare
9.3.5.1 Overview
9.3.5.2 Outpatient Healthcare Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.6 Ambulatory Care Settings
9.3.6.1 Overview
9.3.6.2 Ambulatory Care Settings Market Revenue and Forecasts to 2028 (US$ Mn)
9.4 Home Care
9.4.1 Overview
9.4.2 Home Care Market Revenue and Forecasts to 2028 (US$ Mn)
9.5 Research Laboratories
9.5.1 Overview
9.5.2 Research Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
9.6 Others
9.6.1 Overview
9.6.2 Others Market Revenue and Forecasts to 2028 (US$ Mn)
10. Europe Point of Care Diagnostics Market – Country Analysis
10.1 Europe: Point of Care Diagnostics Market
10.1.1 Overview
10.1.2 Europe: Point of Care Diagnostics Market, By Country, 2020 & 2028 (%)
10.1.3 UK: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.3.1 UK: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.3.2 UK: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.1.3.2.1 UK: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.1.3.3 UK: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.1.3.4 UK: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.1.3.4.1 UK: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.1.4 Germany: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.4.1 Germany: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.4.2 Germany: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.1.4.2.1 Germany: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.1.4.3 Germany: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.1.4.4 Germany: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.1.4.4.1 Germany: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.1.5 France: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.5.1 France: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.5.2 France: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.1.5.2.1 France: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.1.5.3 France: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.1.5.4 France: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.1.5.4.1 France: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.1.6 Italy: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.6.1 Italy: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.6.2 Italy: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.1.6.2.1 Italy: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.1.6.3 Italy: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.1.6.4 Italy: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.1.6.4.1 Italy: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.1.7 Spain: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.7.1 Spain: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.7.2 Spain: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.1.7.2.1 Spain: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.1.7.3 Spain: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.1.7.4 Spain: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.1.7.4.1 Spain: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.1.8 Rest of Europe: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.8.1 Rest of Europe: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.8.2 Rest of Europe: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.1.8.2.1 Rest of Europe: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.1.8.3 Rest of Europe: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.1.8.4 Rest of Europe: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.1.8.4.1 Rest of Europe: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
11. Impact of COVID-19 Pandemic on Europe Point of Care Diagnostics Market
11.1 Europe: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Organic Growth Strategies
12.2.1 Overview
12.3 Inorganic Growth Strategies
12.3.1 Overview
13. Company Profiles
13.1 F. HOFFMANN-LA ROCHE LTD.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Danaher
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 BIO-RAD LABORATORIES INC.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Abbott
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Johnson and Johnson Services, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Siemens AG
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 BD
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 bioMerieux SA
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Polymer Technology Systems, Inc. (PTS)
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Nova Biomedical
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe Point of Care Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Table 2. UK: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 3. UK: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 4. UK: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 5. UK: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 6. UK: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 7. Germany: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 8. Germany: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 9. Germany: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 10. Germany: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 11. Germany: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 12. France: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 13. France: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 14. France: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 15. France: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 16. France: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 17. Italy: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 18. Italy: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 19. Italy: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 20. Italy: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 21. Italy: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 22. Spain: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 23. Spain: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 24. Spain: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 25. Spain: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 26. Spain: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 27. Rest of Europe: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 28. Rest of Europe: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 29. Rest of Europe: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 30. Rest of Europe: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 31. Rest of Europe: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 32. Recent Organic Developments the Point of Care Diagnostics Market
Table 33. Recent Inorganic Developments in the Point of Care Diagnostics Market
Table 34. Glossary of Terms
LIST OF FIGURES
Figure 1. Europe Point of Care Diagnostics Market Segmentation
Figure 2. Europe Point of Care Diagnostics Market Segmentation, By Country
Figure 3. Europe Point of Care Diagnostics Market Overview
Figure 4. Prescription-Based Testing Segment Held Largest Share of Europe Point of Care Diagnostics Market
Figure 5. Germany to Show Significant Growth During Forecast Period
Figure 6. Europe: PEST Analysis
Figure 7. Impact Analysis of Driver and Restraints Pertaining to Europe Point of Care Diagnostics Market
Figure 8. Europe Point of Care Diagnostics Market – Revenue Forecast and Analysis
Figure 9. Europe Point of Care Diagnostics Market, by Products 2020 & 2028 (%)
Figure 10. Europe Glucose Monitoring Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. Europe Infectious Disease Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. Europe HIV Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. Europe Influenza Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. Europe Sexually Transmitted Disease (STD) Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. Europe Hepatitis C Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 16. Europe Healthcare-Associated Infection (HAI) Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. Europe Tropical Disease Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 18. Europe Respiratory Infection Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 19. Europe Others Infection Disease Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. Europe Cardiometabolic Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 21. Europe Pregnancy and Fertility Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 22. Europe Coagulation Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. Europe Tumor/Cancer Marker Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 24. Europe Cholesterol Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 25. Europe Urinalysis Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 26. Europe Haematology Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 27. Europe Other POC Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 28. Europe Point of Care Diagnostics Market, by Prescription Mode 2020 & 2028 (%)
Figure 29. Europe Prescription-Based Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 30. Europe OTC Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 31. Europe Point of Care Diagnostics Market, by End User 2020 & 2028 (%)
Figure 32. Europe Professional Diagnostic Centers Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 33. Europe Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 34. Europe Clinical Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 35. Europe Outpatient Healthcare Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 36. Europe Ambulatory Care Settings Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 37. Europe Home Care Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 38. Europe Research Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 39. Europe Others Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 40. Europe: Point of Care Diagnostics Market, by Key Country- Revenue (2020) (USD Million)
Figure 41. Europe: Point of Care Diagnostics Market, By Country, 2020 & 2028 (%)
Figure 42. UK: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 43. Germany: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 44. France: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 45. Italy: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 46. Spain: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 47. Rest of Europe: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 48. Impact of COVID-19 Pandemic in European Country Markets
- Abbott
- BD
- bioMerieux SA
- BIO-RAD LABORATORIES INC.
- Danaher
- F. HOFFMANN-LA ROCHE LTD.
- Johnson and Johnson Services, Inc.
- Nova Biomedical
- Polymer Technology Systems, Inc. (PTS)
- Siemens AG
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For